Involvement of Interleukin-6 induced PI3K/Akt/mTor pathway in the regulation of telomerase and Alpha-fetoprotein expression in Hepatocellular Carcinoma
Hepatocellular Carcinoma (HCC) is an invasive cancer. Alphafoetoprotein (AFP) is a diagnostic marker for HCC directly related to the disease agressivity. Telomerase, is expressed by 90% of HCC. PI3K/Akt/mTOR pathway wich is regulated by IL-6 is activated in the HCC. Our aim is to investigate the effect of IL-6 on AFP and telomerase secretion in HepG2/C3A and PLC/ PRF/5 cell lines.
Flavin-Containing Dimethylaniline Monooxygenase 5 Drives Malignancies in Hepa...semualkaira
Hepatic microsomes play an important role in drug metabolism,
but the potential biological functions of hepatic microsome-containing proteins in Hepatocellular Carcinoma (HCC) remain unclear. Here, we used HCC and corresponding adjacent Non-Tumor
(NT) tissues to isolate hepatic microsomes and then performed
RNA high-throughput sequencing
Flavin-Containing Dimethylaniline Monooxygenase 5 Drives Malignancies in Hepa...semualkaira
Hepatic microsomes play an important role in drug metabolism, but the potential biological functions of hepatic microsome-con- taining proteins in Hepatocellular Carcinoma (HCC) remain un- clear. Here, we used HCC and corresponding adjacent Non-Tumor (NT) tissues to isolate hepatic microsomes and then performed RNA high-throughput sequencing. After screening, flavin-con- taining dimethylaniline monooxygenase (FMO5) showed a significantly high expression level and was associated with poor prognosis in patients with HCC.
Molecular mechanisms of action and potential biomarkers of growth inhibition ...Enrique Moreno Gonzalez
Molecular targeted therapy has emerged as a promising treatment of Hepatocellular carcinoma (HCC). One potential target is the Src family Kinase (SFK). C-Src, a non-receptor tyrosine kinase is a critical link of multiple signal pathways that regulate proliferation, invasion, survival, metastasis, and angiogenesis. In this study, we evaluated the effects of a novel SFK inhibitor, dasatinib (BMS-354825), on SFK/FAK/p130CAS, PI3K/PTEN/Akt/mTOR, Ras/Raf/MAPK and Stats pathways in 9 HCC cell lines.
chaemoprevention of cancer using dietary phytochemicals awan867
dietary phytochemicals are natural ,non-nutritive ,secondary metabolites .they are mainly for defense system in plants ,also provide colour ,aroma, flavour .they also have anti mutagenic & anti carcinogenic properties . there are 900 phytochemicals but main phytochemicals like curcumin ,gingerol,ECGC, Capsacin and many more . various cell signalling molecules can act as a target for these phytochemicals .
Molecular signaling involved in breast cancerainnie babarrr
Molecular signaling is very important to predict patient's clinical outcome. HER signaling is most important one, by its regulation cascade of pathways started. So, by understanding proteins over-expression we can target with inhibitors to suppress particular protein, which will results in treatment of breast cancer or Drug discovery.
Flavin-Containing Dimethylaniline Monooxygenase 5 Drives Malignancies in Hepa...semualkaira
Hepatic microsomes play an important role in drug metabolism,
but the potential biological functions of hepatic microsome-containing proteins in Hepatocellular Carcinoma (HCC) remain unclear. Here, we used HCC and corresponding adjacent Non-Tumor
(NT) tissues to isolate hepatic microsomes and then performed
RNA high-throughput sequencing
Flavin-Containing Dimethylaniline Monooxygenase 5 Drives Malignancies in Hepa...semualkaira
Hepatic microsomes play an important role in drug metabolism, but the potential biological functions of hepatic microsome-con- taining proteins in Hepatocellular Carcinoma (HCC) remain un- clear. Here, we used HCC and corresponding adjacent Non-Tumor (NT) tissues to isolate hepatic microsomes and then performed RNA high-throughput sequencing. After screening, flavin-con- taining dimethylaniline monooxygenase (FMO5) showed a significantly high expression level and was associated with poor prognosis in patients with HCC.
Molecular mechanisms of action and potential biomarkers of growth inhibition ...Enrique Moreno Gonzalez
Molecular targeted therapy has emerged as a promising treatment of Hepatocellular carcinoma (HCC). One potential target is the Src family Kinase (SFK). C-Src, a non-receptor tyrosine kinase is a critical link of multiple signal pathways that regulate proliferation, invasion, survival, metastasis, and angiogenesis. In this study, we evaluated the effects of a novel SFK inhibitor, dasatinib (BMS-354825), on SFK/FAK/p130CAS, PI3K/PTEN/Akt/mTOR, Ras/Raf/MAPK and Stats pathways in 9 HCC cell lines.
chaemoprevention of cancer using dietary phytochemicals awan867
dietary phytochemicals are natural ,non-nutritive ,secondary metabolites .they are mainly for defense system in plants ,also provide colour ,aroma, flavour .they also have anti mutagenic & anti carcinogenic properties . there are 900 phytochemicals but main phytochemicals like curcumin ,gingerol,ECGC, Capsacin and many more . various cell signalling molecules can act as a target for these phytochemicals .
Molecular signaling involved in breast cancerainnie babarrr
Molecular signaling is very important to predict patient's clinical outcome. HER signaling is most important one, by its regulation cascade of pathways started. So, by understanding proteins over-expression we can target with inhibitors to suppress particular protein, which will results in treatment of breast cancer or Drug discovery.
Inhibition of glutathione by buthionine sulfoximine enhanced the anti-cancer ...Ashujit
Multiple myeloma (MM) is an incurable blood cancer. Melphalan is an alkylating agent given prior to stem cell transplantation to MM patients. Increased glutathione confers resistance to melphalan. This study investigate the effect of inhibition of glutathione by BSO in preclinical models of MM. Pretreatment with BSO enhanced the anti-cancer effect of melphalan in cell lines and animal models. BSO and melphalan combination was well tolerated by animals and enhanced the survival as compared to controls, BSO and melphalan alone. BSO enhanced depth and duration of responses induced by melphalan. In the combination group, majority of treated animals achieved complete response (CR) and more than 20% had maintained CR. Also, the survival of animals was doubled after combination treatment as compared to BSO or melphalan alone. Mechanistic investigation demonstrated that BSO enhanced melphalan induced DNA damage, caspase cleavage and apoptosis. The combination also achieved multi-logs of cells kills in nine human multiple myeloma cell lines and primary MM cells isolated from blood and bone marrows. Interestingly, the effect of BSO and melphalan combination was abolished when cells were treated with N-acetyl cysteine and sodium thiosulfate but not with vitamin C and vitamin E. This observation suggests that effect of BSO is primarily driven by its ability to deplete glutathione and therefore preventing melphalan detoxification. Together, this study provides framework for testing the combination in a Phase I trial.
Effectiveness of Resveratrol on Metastasis: A Reviewiosrphr_editor
The IOSR Journal of Pharmacy (IOSRPHR) is an open access online & offline peer reviewed international journal, which publishes innovative research papers, reviews, mini-reviews, short communications and notes dealing with Pharmaceutical Sciences( Pharmaceutical Technology, Pharmaceutics, Biopharmaceutics, Pharmacokinetics, Pharmaceutical/Medicinal Chemistry, Computational Chemistry and Molecular Drug Design, Pharmacognosy & Phytochemistry, Pharmacology, Pharmaceutical Analysis, Pharmacy Practice, Clinical and Hospital Pharmacy, Cell Biology, Genomics and Proteomics, Pharmacogenomics, Bioinformatics and Biotechnology of Pharmaceutical Interest........more details on Aim & Scope).
PI3Kinase/AKT/mTOR Pathway in Breast Cancer; Pathogenesis and Prevention with...Dr Varruchi Sharma
The most recurrent and considered second most frequent cause of cancerrelated death in women is the breast cancer worldwide. In breast cancer cases patients are usually diagnosed in the beginning at the curable stage. However, its treatment remains a great clinical challenge. A number of studies have been carried out for the treatment of breast cancer which includes the targeted therapies and increased survival rates in women. Essential PI3K/mTOR signaling pathway activation is observed in most breast cancers. The cell growth and tumor development in this case involves phosphoinositide 3 kinase (PI3K)/ Akt/mammalian target of rapamycin (mTOR) pathway. It has been observed, through preclinical and clinical trials, that there are a number of other inhibitors of PI3K/Akt/mTOR pathway, which either alone or in combination with other agents can be used for treatment of cancer. Pre-clinical studies have confirmed that P13K, Akt and mTOR inhibitors achieve anticancer effects by targeting different levels of the PI3K/Akt/mTOR pathway. This chapter evaluates the role of mTOR along with some of its inhibitors and the PI3K/Akt/mTOR pathway in the pathogenesis and prevention of breast cancer.
Increased of Protein O-Fucosyl Transferase 1 and 2 Genes Expression in Gastri...JohnJulie1
Gastric cancer is one of the most common cancers in the world. Gastric cancer usually occurs at an advanced age (average ≥ 65 years) and has symptoms similar to gastric ulcers and other gastric infections, its early diagnosis is one of the major problems of this type of cancer. Molecular mechanisms initiate cancer and the molecular changes of normal cells compared to cancer cells are very important. dysfunction of Fucosyl transferase enzymes is associated with gastric cancer.
Increased of Protein O-Fucosyl Transferase 1 and 2 Genes Expression in Gastri...AnonIshanvi
Gastric cancer is one of the most common cancers in the world. Gastric cancer usually occurs at an advanced age (average ≥ 65 years) and has symptoms similar to gastric ulcers and other gastric infections, its early diagnosis is one of the major problems of this type of cancer. Molecular mechanisms initiate cancer and the molecular changes of normal cells compared to cancer cells are very important. dysfunction of Fucosyl transferase enzymes is associated with gastric cancer.
Increased of Protein O-Fucosyl Transferase 1 and 2 Genes Expression in Gastri...EditorSara
Gastric cancer is one of the most common cancers in the world. Gastric cancer usually occurs at an advanced age (average ≥ 65 years) and has symptoms similar to gastric ulcers and other gastric infections, its early diagnosis is one of the major problems of this type of cancer. Molecular mechanisms initiate cancer and the molecular changes of normal cells compared to cancer cells are very important. dysfunction of Fucosyl transferase enzymes is associated with gastric cancer.
Increased of Protein O-Fucosyl Transferase 1 and 2 Genes Expression in Gastri...NainaAnon
Gastric cancer is one of the most common cancers in the world. Gastric cancer usually occurs at an advanced age (average ≥ 65 years) and has symptoms similar to gastric ulcers and other gastric infections, its early diagnosis is one of the major problems of this type of cancer. Molecular mechanisms initiate cancer and the molecular changes of normal cells compared to cancer cells are very important. dysfunction of Fucosyl transferase enzymes is associated with gastric cancer.
Increased of Protein O-Fucosyl Transferase 1 and 2 Genes Expression in Gastri...semualkaira
Gastric cancer is one of the most common cancers in the world. Gastric cancer usually occurs at an advanced age (average ≥ 65 years) and has symptoms similar to gastric ulcers and other gastric infections, its early diagnosis is one of the major problems of this type of cancer. Molecular mechanisms initiate cancer and the molecular changes of normal cells compared to cancer cells are very important. dysfunction of Fucosyl transferase enzymes is associated with gastric cancer.
Taking away taboos and assist the people who grief: Living a long, happy and ...eshaasini
grief may encompass various symptoms and can be re- garded as a specific, severe form of sorrow. People being circum- vented by the right people and atmosphere, generally experience less difficulties while going through the different phases that em- brace bereavement compared to people who are not. It suggests that besides approaching the symptoms associated with grief, the social elements to combat grief are rather important too. Although social support is acknowledged to be helpful during (traumatic) grief, little information is available about the type of support and behavior that is considered helpful.
The Prognostic Model of Differentiation-Related Lncrna Based on Bioinformatic...eshaasini
Differentiation status of glioma cells correlated with prognosis and Tumor-Immune Microenvironment (TIME) in patients with gliomas. This study aimed to identify difDifferentiation status of glioma cells correlated with prognosis and Tumor-Immune Microenvironment (TIME) in patients with gliomas. This study aimed to identify differentiation-related long non-coding RNAs (DRlncRNAs) that can be used to predict the outcome and the response to immunotherapy in patients with gliomas.ferentiation-related long non-coding RNAs (DRlncRNAs) that can be used to predict the outcome and the response to immunotherapy in patients with gliomas.
More Related Content
Similar to Involvement of Interleukin-6 induced PI3K/Akt/mTor pathway in the regulation of telomerase and Alpha-fetoprotein expression in Hepatocellular Carcinoma
Inhibition of glutathione by buthionine sulfoximine enhanced the anti-cancer ...Ashujit
Multiple myeloma (MM) is an incurable blood cancer. Melphalan is an alkylating agent given prior to stem cell transplantation to MM patients. Increased glutathione confers resistance to melphalan. This study investigate the effect of inhibition of glutathione by BSO in preclinical models of MM. Pretreatment with BSO enhanced the anti-cancer effect of melphalan in cell lines and animal models. BSO and melphalan combination was well tolerated by animals and enhanced the survival as compared to controls, BSO and melphalan alone. BSO enhanced depth and duration of responses induced by melphalan. In the combination group, majority of treated animals achieved complete response (CR) and more than 20% had maintained CR. Also, the survival of animals was doubled after combination treatment as compared to BSO or melphalan alone. Mechanistic investigation demonstrated that BSO enhanced melphalan induced DNA damage, caspase cleavage and apoptosis. The combination also achieved multi-logs of cells kills in nine human multiple myeloma cell lines and primary MM cells isolated from blood and bone marrows. Interestingly, the effect of BSO and melphalan combination was abolished when cells were treated with N-acetyl cysteine and sodium thiosulfate but not with vitamin C and vitamin E. This observation suggests that effect of BSO is primarily driven by its ability to deplete glutathione and therefore preventing melphalan detoxification. Together, this study provides framework for testing the combination in a Phase I trial.
Effectiveness of Resveratrol on Metastasis: A Reviewiosrphr_editor
The IOSR Journal of Pharmacy (IOSRPHR) is an open access online & offline peer reviewed international journal, which publishes innovative research papers, reviews, mini-reviews, short communications and notes dealing with Pharmaceutical Sciences( Pharmaceutical Technology, Pharmaceutics, Biopharmaceutics, Pharmacokinetics, Pharmaceutical/Medicinal Chemistry, Computational Chemistry and Molecular Drug Design, Pharmacognosy & Phytochemistry, Pharmacology, Pharmaceutical Analysis, Pharmacy Practice, Clinical and Hospital Pharmacy, Cell Biology, Genomics and Proteomics, Pharmacogenomics, Bioinformatics and Biotechnology of Pharmaceutical Interest........more details on Aim & Scope).
PI3Kinase/AKT/mTOR Pathway in Breast Cancer; Pathogenesis and Prevention with...Dr Varruchi Sharma
The most recurrent and considered second most frequent cause of cancerrelated death in women is the breast cancer worldwide. In breast cancer cases patients are usually diagnosed in the beginning at the curable stage. However, its treatment remains a great clinical challenge. A number of studies have been carried out for the treatment of breast cancer which includes the targeted therapies and increased survival rates in women. Essential PI3K/mTOR signaling pathway activation is observed in most breast cancers. The cell growth and tumor development in this case involves phosphoinositide 3 kinase (PI3K)/ Akt/mammalian target of rapamycin (mTOR) pathway. It has been observed, through preclinical and clinical trials, that there are a number of other inhibitors of PI3K/Akt/mTOR pathway, which either alone or in combination with other agents can be used for treatment of cancer. Pre-clinical studies have confirmed that P13K, Akt and mTOR inhibitors achieve anticancer effects by targeting different levels of the PI3K/Akt/mTOR pathway. This chapter evaluates the role of mTOR along with some of its inhibitors and the PI3K/Akt/mTOR pathway in the pathogenesis and prevention of breast cancer.
Increased of Protein O-Fucosyl Transferase 1 and 2 Genes Expression in Gastri...JohnJulie1
Gastric cancer is one of the most common cancers in the world. Gastric cancer usually occurs at an advanced age (average ≥ 65 years) and has symptoms similar to gastric ulcers and other gastric infections, its early diagnosis is one of the major problems of this type of cancer. Molecular mechanisms initiate cancer and the molecular changes of normal cells compared to cancer cells are very important. dysfunction of Fucosyl transferase enzymes is associated with gastric cancer.
Increased of Protein O-Fucosyl Transferase 1 and 2 Genes Expression in Gastri...AnonIshanvi
Gastric cancer is one of the most common cancers in the world. Gastric cancer usually occurs at an advanced age (average ≥ 65 years) and has symptoms similar to gastric ulcers and other gastric infections, its early diagnosis is one of the major problems of this type of cancer. Molecular mechanisms initiate cancer and the molecular changes of normal cells compared to cancer cells are very important. dysfunction of Fucosyl transferase enzymes is associated with gastric cancer.
Increased of Protein O-Fucosyl Transferase 1 and 2 Genes Expression in Gastri...EditorSara
Gastric cancer is one of the most common cancers in the world. Gastric cancer usually occurs at an advanced age (average ≥ 65 years) and has symptoms similar to gastric ulcers and other gastric infections, its early diagnosis is one of the major problems of this type of cancer. Molecular mechanisms initiate cancer and the molecular changes of normal cells compared to cancer cells are very important. dysfunction of Fucosyl transferase enzymes is associated with gastric cancer.
Increased of Protein O-Fucosyl Transferase 1 and 2 Genes Expression in Gastri...NainaAnon
Gastric cancer is one of the most common cancers in the world. Gastric cancer usually occurs at an advanced age (average ≥ 65 years) and has symptoms similar to gastric ulcers and other gastric infections, its early diagnosis is one of the major problems of this type of cancer. Molecular mechanisms initiate cancer and the molecular changes of normal cells compared to cancer cells are very important. dysfunction of Fucosyl transferase enzymes is associated with gastric cancer.
Increased of Protein O-Fucosyl Transferase 1 and 2 Genes Expression in Gastri...semualkaira
Gastric cancer is one of the most common cancers in the world. Gastric cancer usually occurs at an advanced age (average ≥ 65 years) and has symptoms similar to gastric ulcers and other gastric infections, its early diagnosis is one of the major problems of this type of cancer. Molecular mechanisms initiate cancer and the molecular changes of normal cells compared to cancer cells are very important. dysfunction of Fucosyl transferase enzymes is associated with gastric cancer.
Similar to Involvement of Interleukin-6 induced PI3K/Akt/mTor pathway in the regulation of telomerase and Alpha-fetoprotein expression in Hepatocellular Carcinoma (20)
Taking away taboos and assist the people who grief: Living a long, happy and ...eshaasini
grief may encompass various symptoms and can be re- garded as a specific, severe form of sorrow. People being circum- vented by the right people and atmosphere, generally experience less difficulties while going through the different phases that em- brace bereavement compared to people who are not. It suggests that besides approaching the symptoms associated with grief, the social elements to combat grief are rather important too. Although social support is acknowledged to be helpful during (traumatic) grief, little information is available about the type of support and behavior that is considered helpful.
The Prognostic Model of Differentiation-Related Lncrna Based on Bioinformatic...eshaasini
Differentiation status of glioma cells correlated with prognosis and Tumor-Immune Microenvironment (TIME) in patients with gliomas. This study aimed to identify difDifferentiation status of glioma cells correlated with prognosis and Tumor-Immune Microenvironment (TIME) in patients with gliomas. This study aimed to identify differentiation-related long non-coding RNAs (DRlncRNAs) that can be used to predict the outcome and the response to immunotherapy in patients with gliomas.ferentiation-related long non-coding RNAs (DRlncRNAs) that can be used to predict the outcome and the response to immunotherapy in patients with gliomas.
Involvement of Interleukin-6 induced PI3K/Akt/mTor pathway in the regulation ...eshaasini
Hepatocellular Carcinoma (HCC) is an invasive cancer. Alphafoetoprotein (AFP) is a diagnostic marker for HCC directly related to the disease agressivity. Telomerase, is expressed by 90% of HCC. PI3K/Akt/mTOR pathway wich is regulated by IL-6 is activated in the HCC. Our aim is to investigate the effect of IL-6 on AFP and telomerase secretion in HepG2/C3A and PLC/ PRF/5 cell lines.
Taking away taboos and assist the people who grief: Living a long, happy and ...eshaasini
grief may encompass various symptoms and can be re- garded as a specific, severe form of sorrow. People being circum- vented by the right people and atmosphere, generally experience less difficulties while going through the different phases that em- brace bereavement compared to people who are not. It suggests that besides approaching the symptoms associated with grief, the social elements to combat grief are rather important too. Although social support is acknowledged to be helpful during (traumatic) grief, little information is available about the type of support and behavior that is considered helpful
The ApoB/A-1 ratio is independently associated with subclinical arteriosclero...eshaasini
The ApoB/ApoA-1 (ApoB/A1) ratio is a pre- dictor of atherosclerotic vascular disease. In this study, we aimed to explore whether ApoB/A1 ratio is related to arteriosclerosis parameters, including subclinical atherosclerosis and arterial stiff- ness, in type 2 diabetic patients.
The Meta-Analysis about the Expression and Prognosis of anti-Ro-52, anti-CENP...eshaasini
We constructed the Meta-analysis to evaluate the existing experimental data and obtain the advantages of the three antinuclear antibodies compared with traditional test items using specific data processing methods and evaluated their value in the diagnosis as well as the differential diagnosis of Sjogren's syndrome and systemic sclerosis. During the process of paper collection, we strictly followed the principle of PICOS to screen the literature, trying to include the literature with a large sample size, controversial and influential results which would make the results of this Meta-analysis more valuable. In this study, Revman and Stata software was used for data processing, and the forest map was drawn to analyze the difference in antibody-positive rate, age, and gender distribution, and other factors. At the same time, a funnel plot was used to evaluate the bias of literature results.
Types of Breast Tissues
•
Fibrous
•
Fibro glandular
•
Adipose (Fatty)
What is Tomosynthesis?
•
Is a 3 dimensional projection
•
Reduces overlapping tissue seen with 2D only
•
15 projections are taken with each combo exposure (7.5) (-7.5)
•
With an average breast (18*24) 3D dose is 1.34, combo is 2.56 Milligrey. (3 Milligrey FDA) (2D is 1.2)
Systematic Review and Meta-Analysis of the Association between β-Blocker Use ...eshaasini
β-blockers are drugs frequently prescribed for various indications in cardiology and for which anticancer properties have been suggested. We aimed to evaluate the association between the use of β-blockers and survival of women with OC.
1.2. Methods: A systematic literature search of relevant databases through September 2020 was conducted to identify studies assessing the association between β-blockers use and prognostic in women with OC. The inverse variance weighting method with random-effects model was used to calculate pooled hazard ratios (HR) and 95% confidence intervals (95% CI). We assessed the risk of immortal time bias (ITB) and the quality of the studies with the Newcastle–Ottawa scale. Subanalyses were performed based on quality scores and the risk for ITB.
IRF5 Promotes the Progression of Hepatocellular Carcinoma and is Regulated by...eshaasini
The IRF family of proteins involves in the tumor progression. However, but the functions of IRF5 in the tumorigenesis are largely unknown. Here, IRF5 was found to be up-regulated in hepatocellular carcinoma (HCC). Interfering with IRF5 inhibited the growth and tumorigenic ability of HCC cells. When studying the molecular mechanism, it was found that TRIM35 interacted with IRF5, promoting the ubiquitination and degradation of IRF5. In the clinical specimens of HCC, TRIM35 was negatively correlated with the expression of IRF5. These observations reveal the oncogenic function of IRF5 in the progression of HCC, suggesting that IRF5 is a promising target for the therapy of HCC.
Benefit of Serum-Thymidine Kinase 1 Concentration for Risk Assessment from Ga...eshaasini
Human Thymidine kinase 1 (hTK1), a key enzyme involved in the DNA synthesis during S-phase of the cell cycle and upregulation of cell proliferation, thus it is reliable tumor proliferating biomarker for assessment of tumor proliferation rate in serum and in tissue in oncology. This meta-analysis is investigation whether the serum TK1 concentration(STK1p)based on hTK1-IgY-polyclonal-antibody can provide a benefit for risk assessment from gastric neoplasm progression to gastric carcinoma (GC) as well as for evaluation of treatment effect in GC.
Prognosis of Invasive Micropapillary Carcinoma of the Breast Analyzed by Usin...eshaasini
Invasive micropapillary carcinoma (IMPC) is a rare type of breast cancer with high frequency of regional lymph node metastasis. However, the prognosis of IMPC has remained controversial for decades. We aimed to compare the differences of prognosis between IMPC and Invasive ductal carcinoma(IDC) of the breast by utilizing Surveillance, Epidemiology, and End Results (SEER) database
Relevant Features and Treatment Options of DLBCL Patients with Late Relapse A...eshaasini
Diffuse large B cell lymphoma (DLBCL) represents the most common type of non-Hodgkin lymphoma (NHL) and it is a potentially curable disease with the current standard of care of immunochemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) especially the addition of rituximab.
Alterations of Gut Microbiota From Colorectal Adenoma to Carcinomaeshaasini
Gut microbiota has been implicated as a critical role in the development of colorectal cancer (CRC) and colorectal adenoma (CRA). However, few basic research has revealed the association between gut microbiota and the development of CRA and CRC. We aim to compare the diversity and composition of intestinal flora in CRA and CRC patients, to reveal the changes of intestinal microorganism in the evolution of normal intestinal mucosa-CRA-CRC axis, and to explore potential biomarkers
Clinic Correlation and Prognostic Value of P4HB and GRP78 Expression in Gastr...eshaasini
Prolyl 4-hydroxylase, beta polypeptide (P4HB) and Glucose‑regulated protein 78 (GRP78) represent for poor prognosis of various cancers, while rare research investigate correlation of them. This study aimed to explore correlation and prognostic value of them in gastric cancer
Combined Analysis of Micro RNA and Proteomic Profiles and Interactions in Pat...eshaasini
The Liquid Mass System(LMS) includes an Easy nLC1000 (Thermo Fisher) coupled ultra-high resolution mass spectrometer Orbitrap Fusion Lumos (Thermo Fisher) with a Thermo Fisher electrospray source. Each injection is sent to a preset column (Acclaim PepMap C18, 100 μm x 2 cm, Thermo Scientific) for adsorption at a flow rate of 3 L/min. The sample is then sent to the analyzer column (Acclaim PepMap C18, 75 μm x 15 cm, Thermo Scientific) for separation.
Το assess CureCancer’s feasibility and patients’ and Oncologists’ satisfaction. CureCancer is a patient-centric/driven platform, which enables patients to self-create their profile, report symptoms, and communicate with physicians.
1.2. Methods: Patients from 9 Centers were asked to register at CureCancer, upload their data and complete a questionnaire on demographics, disease and treatment characteristics, and their satisfaction.
Skeletal muscle channelopathy are rare heterogeneous episodic disorders with marked genotypic and phenotypic variability resulting in periodic paralysis, and falls in young people which often misdiagnosed or undiagnosed due to its rarity, often the symptoms are miscommunicated to the treating phycision due to its episodic nature and not uncommonly physical examination by the time patient attend the clinic or hospital will be unremarkable apart from periodic muscle paralysis where patient will presented to ED with flaccid weakness,
Prevalence of Hpv Infection in the Lekoumou and Niari Departments (Congo Braz...eshaasini
We carried out a descriptive and cross-sectional study over a period of 7 months from January to July 2019 in the department of Lekoumou. 100 women ranging in age from 16 to 73 years old. The variables studied were as follows: age, marital status, level of education, risk factors for the onset of HPV infection, age at first sexual intercourse, number of sexual partners, parity, gesture. The multivariate analysis was done between age, number of level of instruction, parity, age of first sexual intercourse and number of sexual Partners. The statistical analysis and the data processing were carried out by the Excel 2016 software and the graph pad prism version 5 software. The statistical test used was the chi-square test.
The Use of the Infrared Laser Therapy of 890-910 NM for the Treatment Breast ...eshaasini
The experimental studies were conducted with Walker's carcinosarcoma n256 (from the U.S.A. bank), cancer of the mammary gland (RMK-1). Spontaneous –mice with mammary glands cancer (type B). The tasks were as follows: to study the effect of different doses LLLT on the growth of experimental tumors. Evaluation of the effectiveness by applying LLLT in combination with various chemotherapeutic agents
Upper Rectal Cancer: Benefit After Preoperative Chemoradiation Versus Upfront...eshaasini
Upper rectal cancer management is controversial. The present series reports the outcomes of treatment comparing neoadjuvant chemoradiation (NCRT) versus upfront surgery.
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Involvement of Interleukin-6 induced PI3K/Akt/mTor pathway in the regulation of telomerase and Alpha-fetoprotein expression in Hepatocellular Carcinoma
2. clinicsofoncology.com 2
Volume 6 Issue 18 -2022 Research Article
markers has been validated for clinical use. Although it is not the
ideal one, the AFP remains the most important tumor marker for
HCC is human embryonic-fetoprotein (AFP) [6]. The A-Fetopro-
tein (AFP) is a 70 kDa oncofetal glycoprotein composed of the 590
amino acid polypeptide and a carbohydrate moiety, and it is detect-
ed both fetally and maternally during pregnancy [7]. However, in
HCC serum patients, the AFP level is significantly increased, and
this protein is directly related to the aggressivity of the disease [8].
Telomerase is a ribonucleoprotein reverse transcriptase enzyme
complex that serves to elongate the telomeric ends and compen-
sates for the progressive shortening associated with DNA replica-
tion during each cycle of cell division. Telomerase is also known
to be involved in HCC: somatic mutations in the TERT promoter
are the most frequent genetic alterations in human HCC [9]. More-
over, it was reported that telomerase was significantly reactivated
in HCC and other types of chronic liver diseases. However, tel-
omerase activity in Chronic Hepatitis (CH) and Liver Cirrhosis
(LC) is significantly lower than that in atypical adenomatous hy-
perplasia and HCC [10, 11].
In addition toAFPand hTERT upregulation in HCC, PI3K pathway
is also activated in this type of cancer [12]. In fact, the family of
lipid kinases named phosphoinositide 3- kinases (PI3Ks) phospho-
rylates phosphoinositides at the 3′-hydroxyl group [13]. The PI3Ks
play key regulatory roles in many cellular processes including cell
proliferation, survival, and differentiation [14]. They are activated
by Receptor Tyrosine Kinases (RTKs) and their primary role is to
convert PIP2 to PIP3, which in turn activate the serine/threonine
kinase AKT and other downstream effector pathways [15] mTOR
is a key protein in the pathway that acts both upstream and down-
stream of Akt. Akt directly phosphorylates and activates mTOR, as
well as cause indirect activation of mTOR by phosphorylating and
inactivating TSC2 (tuberous sclerosis complex 2, also called tu-
berin) [16]. When activated, mTOR regulates the synthesis of dif-
ferent proteins involved in cell growth, angiogenesis, proliferation
and other cellular endpoints such as S6 kinase proteins (S6K1 and
SK2) [17] and the nuclear Cap-Binding Protein (nCBP) [18].The
most important negative regulator of the PI3K signaling pathway
is the tumor suppressor PTEN (phosphatase and tensin homolog
deleted from chromosome 10) [19]. Recently, studies have showed
that many proteins of the PI3K pathway are frequently targeted by
somatic or germline mutations in a large number of human cancers
[20–22]. These mutations can confer tumourigenic caracteristics in
several cellular systems making the PI3K/Akt/mTOR pathway one
of the most attractive targets for therapeutic strategies in cancer
[23]. We previously reported that telomerase inhibition decreases
AFP production in HCC cell lines. Also, we have demonstrated
that this relationship between AFP and telomerase could be via the
PI3k/Akt/mtor signaling pathway [24].
In this study, we examined the relationship between telomerase,
AFP and the pro-inflammatory cytokine IL-6 due to the several
reasons. First, hTERT mRNA and AFP mRNA are up-regulated
in the multistep process of hepatocarcinogenesis [25]. Second, the
PI3K/Akt/mTOR signaling pathway that is thought to be involved
in the regulation of AFP [26] and hTERT [27], is regulated by in-
terleukin-6 [28]. In fact, IL-6 induces Akt/PKB phosphorylation in
a time and dose dependent manner in multiple myeloma. The IL-6
induces the phosphorylation of downstream targets of Akt, includ-
ing Bad, GSK-3β, and FKHR [29]. In addition, increased levels of
interleukin (IL)-6 have been reported to associate with and have a
negative survival impact on patients with various types of cancer
including HCC. Moreover, IL-6 has been shown to link with some
human cancers as well as HCC [30–32]. However, the potential
role of IL-6, as tumor marker for HCC and its relationship with
AFP is not fully clear.
3. Results
3.1. Dose-response curve effect of Interleukin-6 on AFP expres-
sion and secretion and on hTERT expression
In our study, we focused on evaluating the effect of interleukin-6
on the expression and secretion of AFP as well as the expression of
hTERT. The figure 1 shows that treatment of HepG2 / C3A cells by
IL-6 at different concentrations (2, 5 and 10 ng / ml) for 24 hours
did not have any significant effect on the secretion of AFP in the
cell supernatant. However, IL-6 (25ng / ml) significantly decreased
the concentration of AFP in the supernatant of HepG2 / C3A cells.
The same pattern was observed in PLC/PRF/5 cell line. This effect
is also observed at the mRNA level of AFP (30% decrease after
treatment with IL-6 at 25 ng / ml) in both cell lines. Moreover, IL-6
reduces the expression of hTERT at a concentration of 5 ng / ml by
20%). The effect was more pronounced at higher concentrations
of IL-6, 10 and 25 ng / ml, (40 and 50%, respectively) in HepG2/
C3A cells while, in PLC/PRF/5 cells, IL-6 reduces the expression
of hTERT only at a concentration of 25ng/ml by 30% (Figure 2).
3. clinicsofoncology.com 3
Volume 6 Issue 18 -2022 Research Article
Figure 1: Effect of Interleukin-6 on AFP secretion in HepG2 / C3A and PLC/PRF/5 cells.
The cells are seeded in 6-well plates at a density of 2x105 cells / well. At 80% confluence, the cells were treated with interleukin-6 (2, 5, 10 or 25 ng /
ml) for 24h. The supernatant was then collected and evaluated by ELISA. Each value represents the average of three experiments. Each value has its
own control which was defined as 100%. Each point represents a mean + / _ SD for all experiments. ** P <0.005 compared to untreated cells.
Figure 2: Effect of interleukin-6 on the mRNA expression of AFP and hTERT by HepG2 / C3A and PLC/PRF/5cells. Cells were seeded in 75 cm2
flasks in DMEM 1g / L. At 80% confluence, the cells were treated with interleukin-6 (2, 5,10 or 25 ng / ml) for 24h. RNA was extracted from cells for
RT-PCR. The amplified DNA was then loaded on an 2% agarose gel and visualized by sybersafe staining. The relative mRNA expression was obtained
by using the software Gelanalyzer.
4. clinicsofoncology.com 4
Volume 6 Issue 17 -2022 Research Article
3.2. Time course effect of interleukin-6 on AFP secretion and
expression
Since IL-6 (25 ng / ml) significantly decreased the concentration
of AFP in the supernatant of HepG2 / C3A cells after 24 hours of
treatment, we have established a curve in time showing the ef-
fect of IL-6 (25 ng / ml) after various periods of treatment . This
experiment gave us a clearer idea of the regulation of AFP by IL-
6. Indeed, the figure 3 shows that IL-6 (25ng / ml) significantly
reduces the concentration of AFP in the cell supernatant after 4
hours of treatment in HepG2/C3A cells and after 2 hours in PLC/
PRF/5 cells. However, at 8 hours of treatment, this concentration
increases significantly before falling again after 24 hours in both
cell lines. This profile is also observed at the mRNA level of AFP.
However, the transient effect of IL-6 on hTERT is less clear (Fig-
ure 4). Indeed, in HepG2/C3A cells, the expression of the hTERT
was reduced by 20 and 25% after treatment with IL-6 for 2 and 4
hours respectively. After 6 hours of treatment, the expression of
hTERT is comparable to that in the control, then after 8 hours of
treatment, its expression increases to 20% prior to of its decrease
by 30 to 50% after treatment for 10 and 24 hours respectively.
While in PLC/PRF/5 cells, the expression of the hTERT was re-
duced by 30% after treatment with IL-6 for 2 hours. Then after 8
hours of treatment, the expression increases to 20%.After 10 hours
of treatment, hTERT expression is comparable to that in the con-
trol well, while after 24 hours of treatment, the hTERT expression
decreases by 40%.
Figure 3: Time course effect of interleukin-6 on the AFP secretion.
The cells are seeded in 6-well plates at a density of 2x105 cells / well. At 80% confluence, the cells were treated with interleukin-6 at 25 ng / ml for
2, 4, 6.8 10 or 24. The supernatant was then collected and evaluated by ELISA. Each value represents the average of three experiments. Each value
has its own control which was defined as 100%. Each point represents a mean + / _ SD for all experiments. ** P <0.005 compared to untreated cells.
5. clinicsofoncology.com 5
Volume 6 Issue 17 -2022 Research Article
Figure 4: Effect of interleukin-6 on the mRNA expression of AFP and hTERT in HepG2 / C3A and PLC/PRF/5 cells.Cells were seeded in 75 cm2 flasks
in DMEM 1g / L. At 80% confluence, the cells were treated with interleukin-6 at 25 ng / ml for 2, 4,6,8, 10 or 24h. RNA was extracted from cells for
RT-PCR. The amplified DNA was then loaded on an agarose 2% gel and visualized by staining sybersafe. The relative mRNA expression was obtained
by using the Gelanalyzer software.
3.3. Effect the PI3K / Akt / mTOR pathway inhibitors and IL-6
on the expression and the secretion of AFP and on the expre-
sion of the hTERT
To assess the involvement of the PI3K / Akt / mTOR pathway in
the relationship between AFP, IL-6 and telomerase, we proceed to
study the effect of inhibitors of this pathway and the effect inhibi-
tors of telomerase on AFP in HepG2 / C3A and PLC/PRF/5 cells.
As shown in figure 5, the inhibition of PI3K, Akt and mTOR by
wortmanin (5 nM), niclosamide (31 nM) and rapamycin (200 nm)
for 8 hours, respectively, significantly decreased the concentration
of AFP in the supernatant of HepG2 / C3A cells after one hour
of treatment. This effect is also observed after 8 hours of treat-
ment. The treatment of HepG2 / C3A and PLC/PRF/5 cells by
interleukin-6 (25ng / ml) for 8 hours significantly increased the
concentration of AFP in the cell supernatant (70%). However, the
combination of pathway inhibitors PI3K/Akt/mTOR with IL-6
decreased the concentration of AFP in the supernatant suggesting
that the regulation of AFP by IL-6 passes through this signaling
pathway. LPS (lipopolysaccharide), an activator of telomerase did
not have a significant effect on the concentration of AFP. However,
inhibition of telomerase by the costunolide (10uM) and BIBR1532
(10uM) significantly decreased the concentration of AFP by 50
and 70% respectively in HepG2/C3A cells and by 40% and 30% in
PLC/PRF/5 cells . The combination of telomerase inhibitors with
IL-6 further increased the concentration of AFP. The relationship
between AFP and PKC was also studied in this experiment, since
PKC is known to be overexpressed in cancers and regulated by
telomerase. Indeed, activation of PKC by PMA (phorbol ester)
significantly increased the concentration of AFP by 60% and 70%
in HepG2/C3A and PLC/PRF/5 cells respectively. The combina-
tion of PMA and IL-6 reinforced this effect and showed an ad-
ditive effect / synergistic between the two molecules. Similarly,
treatment of cells with the PKC inhibitor (SPC028) decreased the
concentration of AFP in the supernatant (60% and 40% in HepG2/
C3A and PLC/PRF/5 respectively, however the combination of
IL-6 with the SPC028 restored this inhibition. The same pattern
was observed with HepG2/C3A cells at the hTERT and the mRNA
level of AFP except for PMA where the significance was not
reached on the mRNA of hTERT in combination with IL-6 (25ng
/ ml) (Figure 6A). PLC/PRF/5 cells treatment with IL-6 (25ng/
ml) increases AFP and hTERT expression after 8 hours (40 and
80% respectively), the expression of the two genes decreases when
IL-6 was combined with PI3K, mTOR and STAT-3 inhibitors. In-
hibition of telomerase by the costunolide (10uM) and BIBR1532
(10uM) significantly decreased the expression of AFP by 20 and
25% respectively. However, only BIBR1532 had a significant ef-
fect on the expression of hTERT (40%) . The combination of tel-
omerase inhibitors with IL-6 increased once again the expression
of AFP and hTERT. The PKC inhibitor had a significant effect on
AFP expression but not on hTERT expression (Figure 6B).
6. clinicsofoncology.com 6
Volume 6 Issue 17 -2022 Research Article
Figure 5: Effect of interleukin-6, inhibitors of PI3K / Akt / mTOR pathway and telomerase inhibitors on the secretion of AFP by HepG2 / C3A and
PLC/PRF/5 cells.
The cells are seeded in 6-well plates at a density of 2x105 cells / well. At 80% confluence, the cells were treated by inhibitors of the PI3K / Akt / mTOR
pathway for 1h. Then IL-6 was added with or without the inhibitors mentioned in the figure and the treatment of cells was carried out for 8 hours. The
supernatant was then collected and evaluated by ELISA. Each value represents the average of three experiments. Each value has its own control which
was defined as 100%. Each point represents a mean + / _ SD for all experiments. ** P <0.005 compared to untreated cells.
Figure 6: Effect of interleukin-6, inhibitors of the PI3K / Akt / mTOR pathway and telomerase inhibitors on the mRNA expression of AFP and hTERT
in HepG2 / C3A and PLC/PRF/5 cells. The cells are seeded in 75 cm2 flasks in DMEM 1g / L. At confluence 80%, the cells were treated by inhibitors
of the PI3K / Akt / mTOR pathway for 1h. Than IL-6 was added with or without the inhibitors mentioned in the figure and the treatment of cells was
carried out for 8 hours. RNA was extracted from cells for RT-PCR. The amplified DNA was then loaded on an 2% agarose gel and visualized by staining
sybersafe. The relative mRNA expression was obtained by using the software Gelanalyzer
7. clinicsofoncology.com 7
Volume 6 Issue 17 -2022 Research Article
3.4. Effect of telomerase inhibitors on the expression of the
components of the PI3K / Akt / mTOR pathway
The PI3K / Akt / mTOR pathway is known to regulate the expres-
sion of hTERT and telomerase activity [33,34]. The aim of this
experiment was to explore the interaction between telomerase and
the PI3K / Akt / mTOR pathway (Figure 7). A shows that the inhi-
bition of telomerase by costunolide and BIBR1532 (5 and 10uM)
increases the secretion of the non-phosphorylated form of Akt pro-
tein and STAT-3 in HepG2 / C3A cells, whereas only costunolide
(10uM) and BIBR1532 (5 and 10uM) decreased the secretion of
the phosphorylated form of the two proteins. Moreover, the secre-
tion of the two forms, phosphorylated and non-phosphorylated, of
the mTOR protein decreased significantly after treatment with the
telomerase inhibitors at 5 and 10uM. However, the effect of tel-
omerase inhibitors was slightly different in PLC/PRF/5 cells (Fig-
ure 7B). In fact, only costunolide at 10uM increases the secretion
of the non-phosphorylated form of Akt protein and STAT-3, while
BIBR1532 (5uM) increases the secretion of the non-phospho-
rylated form STAT-3 protein. Costunolide and BIBR1532 (5 and
10uM) decreased the secretion of the phosphorylated form of the
two proteins. Moreover, the secretion of the two forms, phospho-
rylated and non-phosphorylated, of the mTOR protein decreased
significantly after treatment with costunolide (5uM).
Figure 7: Effect of telomerase inhibitors of the PI3K / Akt / mTOR pathway in HepG2 / C3A and PLC/PRF/5 cells. Cells are seeded in 75cm2
flasks in DMEM containing 1g / L glucose. At 80% confluence, the HepG2 / C3A and PLC/PRF/5 cells are treated with the costunolide (5 or 10um)
or BIBR1532 (5or 10um) for 48 h. Proteins were extracted with a lysis buffer and a Western blot was performed as described in the "materials and
methods". The relative expression of the protein compared with the expression of B-actin is obtained using the Gelanalyzer software.
8. clinicsofoncology.com 8
Volume 6 Issue 17 -2022 Research Article
3.5. Effect of interleukin, inhibitors of the PI3K / Akt / mTOR
pathway and telomerase inhibitors on telomerase activity
To explore the effect of IL-6 as well as the effect of telomerase in-
hibitors and the PI3K / Akt / mTOR pathway inhibitors in HepG2
/ C3A and PLC/PRF/5 cells, the measurement of telomerase ac-
tivity was performed. As shown in Figure, IL-6 (25ng / ml) acti-
vates telomerase whereas the inhibitors of the PI3K / Akt / mTOR
(Wortmanin, Rapamycin and Niclosamide) show an inhibition ef-
fect after 8h. Inhibitors combining with IL-6, it is noted that acti-
vation of IL-6 is lifted in comparison with IL-6 alone. In addition,
the treatment of cells with telomerase inhibitors, costunolide and
BIBR 1532 and with the PKC inhibitor SPC028, decreases the tel-
omerase activity in a very significant way (Figure 8).
3.6. Investigation of the relation between AFP and telomerase
by EMSA
Several transcription factors have been reported to be involved in
the regulation of the AFP gene, including Nkx2.8, HNF1, CEBP,
NF1, RAR and RXR. Since CEBP is a common transcription fac-
tor between AFP and telomerase, our goal is to evaluate the effect
of telomerase inhibitors on CEBP by gel shift. As shown in fig-
ure 9, BIBR1532 did not have an effect on CEBP binding to AFP
promoter in HepG2/C3A and PLC/PRF/5 cells. Surprisingly, treat-
ment with costunolide (10uM) for 48 hours induced the binding of
CEBP to AFP promoter in both cell lines.
Figure 8: Effect of IL-6 inhibitors and telomerase inhibitors of the PI3K / Akt / mTOR on telomerase activity. Cells are seeded in 6 well plates in
DMEM 1g/L. At 80% confluence, cells are treated with inhibitors of the PI3K / Akt / mTOR pathway, telomerase inhibitors and IL-6 (25ng/L). Proteins
were extracted with a lysis buffer then a qPCR was performed. Each value represents the average of three experiments. Each point represents a mean +
/ _ SD for all experiments. ** P <0.005 compared to untreated cells.
Figure 9: Effect of telomerase inhibitors on CEBP. Cells are seeded in 6 well plates in DMEM 1g/L.At 80% confluence, cells are treated with BIBR1532
and costunolide at 10µM for 48h. Proteins were extracted with a lysis buffer and a gel shift was performed as described in the "materials and methods".
9. clinicsofoncology.com 9
Volume 6 Issue 17 -2022 Research Article
4. Discussion
Telomerase activity is an important element in malignant trans-
formation [35]. This study shows that telomerase inhibition de-
creased AFP secretion and expression in hepatocellular cell lines
via the PI3K/Akt/mTOR, the anabolic pathway that regulate the
telomerase activity.. In addition to an enhanced telomerase activ-
ity, malignant tumors are characterized by aberrant growth signa-
ling mechanisms that permit escape from physiological controls
of cell growth [36,37]. The major findings of our studies are that
IL-6, a biliary epithelial mitogen, increases telomerase activity and
AFP expression in HepG2/C3A and PLC/PRF/5 cells, involving
the activation of PI3K/Akt/mTOR pathway. Thus, IL-6 stimula-
tion may contribute to hepatocellular growth by increasing AFP
secretion as well as promoting telomerase activity. Moreover, we
demonstrated that the transcription factor C/EBP is not involved in
this interrelationship between AFP and telomerase.
IL-6 has been implicated, as an autocrine promoter, of several
types of cancer such as CCAs (biliary tract epithelial cancers) [38],
multiple myeloma [39] and prostate cancer growth [40]. Thus, the
regulation of telomerase expression by this cytokine may represent
a unique mechanism resulting in tumor growth and progression.
Our results support the presence of a dominant IL-6 stimulated
pathway that increases telomerase expression and activity through
the PI3K/Akt/mTOR pathway. Moreover, this pathway may be
implicated in AFP regulation in hepatocellular carcinoma cells. In
fact, it was demonstrated, in this study, that IL-6 increased AFP
secretion and expression after 8h of treatment in a dose-dependant
way. Potapovich et al. have showed that AFP may modulate in-
flammatory events in human keratinocytes by de novo expression
of a number of pro-inflammatory mediators and modulation of
their pro-inflammatory response to cytokines including IL-6 [41].
Recently, Zheng et al. have shown that AFP increases prolifera-
tion of hepatocellular carcinoma cells by stimulating PI3K / Akt
/ mTOR pathway. In fact, comparing with cirrhosis patients and
control group, patients suffering from HCC, have serum level of
AFP considerably increasing as the mRNAexpression of PI3K and
Akt. In addition, after incubation of HepG2 cells (which strong-
ly express AFP) with monoclonal antibodies or AFP inhibitors,
the expression of PI3K and Akt was significantly decreased [42].
These results point in the same direction as the results found by
ZHU Zhi-Li and his colleagues have studied the correlation be-
tween PI3K, AFP and phosphorylated Akt (p-Akt). Indeed, a pos-
itive correlation was found between the three effectors. Addition-
ally, this team showed that the expression of PI3K, p-Akt and AFP
is very important in the growth of hepatocellular carcinoma and
the expression of AFP can activate the PI3K / Akt pathway [43].
In our study, we showed that IL-6 increased AFP secretion in cells
supernatant after 8h of treatment, then, when PI3K/Akt/mTOR in-
hibitors were combined with IL-6, AFP secretion decreased. These
results suggest that IL-6 regulates AFP secretion through PI3K/
Akt/mTOR pathway in hepatocellular carcinoma, andshow that
it could be a close link between inflammation and hepatocellular
carcinoma. Indeed, several authors have focused on this relation-
ship. Barashi et al. recently showed that in a mouse model with
HCC and lacking the CCR5 chemokine receptor, recruitment of
macrophages and traffic to the liver were significantly reduced. In
addition, in the absence of CCR5, the mice showed a significant
decrease in tumor size in the liver [44]. Moreover, Capece et al.
stated in their review of the literature that Tumor Associated Mac-
rophages (TAM) play a central role in the case of hepatocellular
carcinoma. Indeed, the TAM activate the growth of hepatocellular
carcinoma cells (HCC), angiogenesis, invasion and metastasis, as
well as the suppression of anti-tumor immune response by inter-
acting with stromal and cancer cells within the microenvironment
of the tumor.TAM release of many cytokines, chemokines and
growth factors, which are involved in tumorigenesis. In particular,
IL-6 and TGF factor which promote tumor growth, whereas TNF-
αand tumor Metalloproteinases (MMPs) are involved in invasion
and metastasis [45].
In the last recent years, several authors have been interested in the
study of signaling pathways, especially the PI3K / Akt / mTOR
pathway, which regulate hTERT and the activity of telomerase.
Mengsen et al. have shown that mTOR can regulate directly or
indirectly the activity of telomerase in HCC cell. However, there
is no report on the role of chemotherapeutic agents on mTOR
and its role in regulating the expression of hTERT profiles. Their
results suggest that treatment of the cell line HCC SMMC-7721
with 5-fluouracile could downregulate the secretion both mTOR
and telomerase activity. In addition, inhibition of mTOR leads to
a decrease in telomerase activity at post-transcriptional level [46].
In addition, a study by Bellon et al. showed that inhibition of
PI3K / Akt pathway reduces telomerase activity 33. The relation-
ship between hTERT and PI3K / Akt pathway has been studied by
Kawaushi et al. This team has found that stimulation of human NK
cells (natural killer) IL-2 induces activation of the hTERT and the
mechanism of activation of the hTERT after stimulation by IL-2
involves transcriptional regulation or post-translational through
the PI3K / Akt / mTOR pathway. All these studies have shown
that inhibition of PI3K / Akt / mTOR inhibits the expression of
the hTERT or telomerase activity [47]. In our study, the opposite
effect was studied for the first time, namely the effect of inhibi-
tion of telomerase on the components of the PI3K / Akt / mTOR
pathway. Our results clearly show that telomerase inhibition by
costunolide BIBR 1532 leads decrease the secretion of the com-
ponents of the PI3K / Akt / mTOR after a 48 hours treatment as
well as telomerase activity in HepG2 / C3A cells and PLC / PRF /
5 cells of hepatocellular carcinoma. Finally, this study shows that
CEBP, a critical regulator of several hepatic metabolic processes,
was not implicated in the relationship between AFP and telomer-
ase. In fact, telomerase inhibition by BIBR1532 had no effect on
10. clinicsofoncology.com 10
Volume 6 Issue 17 -2022 Research Article
CEBP binding to AFP. Further studies are needed to explore the
mechanism by which telomerase regulate AFP in hepatocellular
carcinoma cells.
5. Materiel and Methods
5.1. The choice of cell lines
HepG2 / C3A cells: HepG2 / C3A cells are a hepatocellular car-
cinoma cell line provided by Baylor College of Medicine, main-
tained by ATCC (American Type Cell Culture) in the United
States. HepG2 / C3A strongly express telomerase and secrete al-
most all proteins normally found in normal serum and also the
AFP. These cells are cultured in our laboratory as recommended
by ATCC (American Type Cell Culture). Indeed, HepG2 / C3A
are cultured in DMEM + 10% FBS (Fetal bovine serum) + 1% P
/ S (penicillin / streptomycin) + 1% NEAA (Non Essential amino
acids) and incubated at 37 ° in an incubator at 5% CO2
PLC / PRF /
5 cells: PLC / PRF / 5 cell line is another hepatocellular carcinoma
maintained by the ATCC in the USA. PLC / PRF / 5 express tel-
omerase and AFP. In addition, these cells also express the surface
antigen of hepatitis B (HBsAg) .As HepG2 / C3A, PLC / PRF / 5
were grown in our laboratory according to the recommendations
of ATCC. Indeed, PLC / PRF / 5 were grown in DMEM + 10%
FBS (Fetal bovine serum) + 1% P / S (penicillin / streptomycin)
and incubated at 37 ° in an incubator with 5% CO2
.
5.2. Measurement of human AFP in cell supernatant
The concentration of human AFP in the cell supernatant was meas-
ured using an ELISA kit from HUMAN Company (GmbH) ac-
cording to the manufacturer’s recommendations. Briefly, HepG2
/ C3A and PLC / PRF / 5 cells were seeded in 75 cm2
flasks in
culture medium. At 80% confluence, the cells were treated as de-
scribed in the figure legends. The supernatant was then collected
and diluted 1:50 with serum free media for ELISA; however, the
supernatant of PLC / PRF / 5 was not diluted. The ELISA method
is based on the affinity of biotin for streptavidin attached to the sur-
face of a microtiter well. The enzyme-antibody conjugate is mixed
with samples and standards to form the sandwich complex. After
incubation and washing, substrate is added and the formed product
is evaluated by reading the optical density using an ELISA reader
at 450nm. The intensity of the color developed by the product is
directly proportional to the concentration of AFP in the samples.
5.3. Cell viability test
Cell viability was determined using the tetrazolium salt 3- (4,5-di-
methylthiazol-2-yl) -5- (3-carboxymethoxyphenyl) -2- (4-sul-
fophenyl) -2H as reported by the manufacturer’s instructions
(Sigma-Aldrich). The tetrazolium salt is cleaved to formazan by
succinate- reductase, an enzyme that exists only in the mitochon-
drial respiratory chain and is active only in viable cells. Formazan
production is proportional to the number of living cells in culture.
Briefly, HepG2 / C3A and PLC / PRF / 5 were seeded at 104
cells
per well in 96 well plates. At 80% confluence, the cells were treat-
ed with IL-6, PI3K/Akt/mTOR or telomerase inhibitor for 48 h.
After treatment, 10 ul of tetrazolium salt were added to 100 uL of
culture medium, and the plate was incubated for 45 min at 37ºC.
Absorbance was then measured using an ELISA reader at 450 nm.
5.4. RNA extraction and RT-PCR
Total RNA from HepG2 / C3A and PLC / PRF / 5 was extracted
using the kit “GenElute Mammalian Total RNA Kit” from Sig-
ma-Aldrich according to manufacturer’s instructions. The cDNA
was synthesized from 1 ug of RNA using the kit “iScript cDNA
Synthesis” (Bio-Rad). Quantitative PCR was performed using the
kit REDTaq Ready Mix PCR Reaction Mix (Sigma-Aldrich). The
PCR primers have the following sequences:
AFP forward 5’-ACCCTGGTGTTGGCCAGT’-3’; AFP re-
verse 5’-GCAGCGCTACACCCTGAGT-3’; hTERT forward
5’-TGAACTTGCGGAAGACAGTGG -3 ‘; hTERT reverse
5’-ATGCGTGAAACCTGTACGCCT-3’; GAPDH forward
5’-TGGGATGGACTGTGGTCATGAG-3; GAPDH reverse
5’-ACTGGCGTCTTCACCACCATGG-3’
The DNA was amplified for 35 successive cycles (denaturation: 95
° C, 30 sec; annealing of the primers: 60 ° C, 1 min and elongation
72 ° C, 5 min). The amplified DNA was then run in an agarose gel
at 2% and visualized by staining with SYBR Safe using the system
BioDoc UVP.
5.5. Western blot
Cells were seeded in 75cm2 flasks with DMEM culture medi-
um). At 80% of confluence, cells were treated by costunolide (5
or 10uM) and BIBR1532 (5 or 10uM) for 48 hours and the IL-6
(5.10 or 25 ng / ml) for 8h and 24h. After treatment, proteins were
extracted from the cells with a lysis buffer comprising the follow-
ing compounds: 50 mM NaCl, 5 mM EDTA, Triton X-100 1%
(detergent allowing the destructuring of membranes), 50 mM NaF,
Na4P2O7 10 mM protease inhibitor cocktail Roche® (Complete
™ Mini Protease Inhibitor cocktail), pH 7.5 for 30 min at 4 ° C.
Cell debris were then removed by centrifugation at 10 000g for 10
min at 4 ° C.Extracted proteins are then denatured by adding a de-
naturing solution (Lamelli buffer 2x) and 2 ul B-mercaptoethanol
to a final volume of 20ul. The mixture is then incubated for 5 min
at 95ºC. Once denatured, the proteins are separated on an SDS-
PAGE denaturing acrylamide gel in which the percentage varies
depending on the molecular weight of the protein to be detected.
The proteins in the gel were then transferred onto a PVDF mem-
brane by applying a current of 360mA intensity for 1 h. The mem-
brane is then immersed in a solution of 5% milk for 1 hour with
stirring to saturate the sites of nonspecific interactions of the mem-
brane. The primary antibody (akt, mTOR or STAT-3 under their
phosphorylated or unphosphorylated form) was diluted and incu-
bated with the membrane overnight. The next day, the membrane
was rinsed with a wash solution, and then the secondary antibody
coupled to peroxidase was added and incubated with the mem-
11. clinicsofoncology.com 11
Volume 6 Issue 17 -2022 Research Article
brane for one hour and a half. The membrane was then placed in
the presence of reactive chimiolumininescent UptiLight blot HRP
™ substrate (Uptima®) prepared according to the manufacturer’s
protocol in the dark. After one minute of incubation, the revelation
was made using the UVP Biodoc system.
5.6. Measurement of telomerase activity
To see the effect of IL-6 and inhibitors of the PI3K / Akt / mTOR
on the telomerase activity of cells, we used the kit “Quantitive
Telomerase Detection Kit” of Allied Biotech Company. Briefly,
HepG2 / C3A and PLC/PRF/5 cells were seeded as mentioned
above and then treated with PI3K, Akt and mTOR inhibitors for
1h. Then, IL-6 (25ng / ml) was added and the treatment was per-
formed during 8h. After treatment, the cells were incubated 30min
on ice with lysis buffer then centrifuged at 14000rpm at 4 ° C
for 30 minutes to extract telomerase. A dilution series was then
produced from a solution of oligonucleotides having the same
sequence as that of telomers (TSR) and a master mix containing
primers telomere is added to each tube. Next, quantitative PCR
was performed using the following protocol (Table 1).
Steps Time Temperature Comments
Telomerase Reaction 20 min 25oC
Telomere templates were formed by adding 6-base-repeates to primer
with the activity of telomerase
PCR Initial Activation Step 10 min 95oC HotActivitedTag DNA Polymerase is activated by this heating step
3-step cycling:
Denaturation 30s 95oC
Annealing 30s 60oC
Extention 30s 72oC
Cycle number 35-40 cycles Cycle number depends on the amount of template DNA.
Table 1:
5.7. Gel shift assay
Single-stranded biotin-labeled oligonucleotides containing C/
EBP consensus DNA binding site were purchased from Bio-Rad.
Double-stranded oligonucleotides were prepared by annealing
complementary oligonucleotides in a buffer containing 10 mM
Tris (pH 8.0), 50 mM NaCl, and 1 mM EDTA. The sequence of
the complementary pairs are as follow: AFP C/EBP, -118 to -97,
5’-CAAATTGCCTAACTTCAACATA-3’, CEBP-BIOTEG-1
5’-TGCAGATTGAAGCAATTTCCTCCTGCA-3’, CEBP 3’
ACGTCTAACTTCGTTAAAGGAGGACGT-5’. For the EMSA,
labeled double-stranded oligonucleotides were incubated with nu-
clear cell extracts in a binding buffer containing 10 mM Tris (pH
8.0), 1mM EDTA, 50 mM NaCl, BSA (1.45 mg/ml), glycerol and
poly d(I-C) (1 μg/μl).
5.8. Statistical Analysis
Results were assessed by t-test using the Graph-Pad Quickcalcs
online software (http://www.graphpad.com/quickcalcs/ttest1.
cfm). Values are expressed as means SD.
6. Funding
This work was supported,in whole or in part,by the Research
Council of Saint-Joseph University and the Lebanese National
Council for Scientific Research (CNRS).The funders had no role
in study design,data collection and analysis,decision to publish,or
preparation of the manuscript.
References
1. Altekruse SF, Henley SJ, Cucinelli JE, McGlynn KA. Changing he-
patocellular carcinoma incidence and liver cancer mortality rates in
the United States. Am J Gastroenterol. 2014; 109: 542-53.
2. Marrero JA, Su GL, Wei W, Emick D, Conjeevaram HS, Fontana
RJ, et al. Des-gamma carboxyprothrombin can differentiate hepato-
cellular carcinoma from nonmalignant chronic liver disease in amer-
ican patients. Hepatol. Baltim Md. 2003; 37: 1114-21.
3. Matsuda M, Asakawa M, Amemiya H, Fujii H. Lens culinaris ag-
glutinin-reactive fraction of AFP is a useful prognostic biomarker
for survival after repeat hepatic resection for HCC. J. Gastroenterol.
Hepatol. 2011; 26: 731–738.
4. Christa L, Simon MT, Brezault-Bonnet C, Bonte E, Carnot F, Zyl-
berberg H, et al. Hepatocarcinoma-Intestine-Pancreas/Pancreatic
Associated Protein (HIP/PAP) Is Expressed and Secreted by Prolif-
erating Ductules as well as by Hepatocarcinoma and Cholangiocar-
cinoma Cells. Am. J. Pathol. 1999; 155: 1525-33.
5. Huynh H, Chow PKH, Ooi LLP, Soo KC. A possible role for insu-
lin-like growth factor-binding protein-3 autocrine/paracrine loops in
controlling hepatocellular carcinoma cell proliferation. Cell Growth
Differ. Mol. Biol. J. Am. Assoc. Cancer Res. 2002; 13: 115-22.
6. Bialecki ES, Di Bisceglie AM. Diagnosis of hepatocellular carcino-
ma. HPB. 2005; 7, 26–34.
7. Mizejewski GJ. Biological roles of alpha-fetoprotein during preg-
nancy and perinatal development. Exp. Biol. Med. Maywood NJ.
2004; 229: 439-63.
8. Arrieta O, Cacho B, Morales-Espinosa D, Ruelas-Villavicencio A,
Flores-Estrada D, Hernández-Pedro N. The progressive elevation
of alpha fetoprotein for the diagnosis of hepatocellular carcinoma in
patients with liver cirrhosis. BMC Cancer. 2007; 7: 28.
12. clinicsofoncology.com 12
Volume 6 Issue 17 -2022 Research Article
9. Nault JC, Mallet M, Pilati C, Calderaro J, Bioulac-Sage P, Laurent
C, et al. High frequency of telomerase reverse-transcriptase promot-
er somatic mutations in hepatocellular carcinoma and preneoplastic
lesions. Nat. Commun. 2013; 4.
10. Chen CJ, Tsai NM, Liu YC, Ho LI, Hsieh HF, Yen CY, et al. Telo-
merase activity in human hepatocellular carcinoma: parallel correla-
tion with human telomerase reverse transcriptase (hTERT) mRNA
isoform expression but not with cell cycle modulators or c-Myc ex-
pression. Eur. J. Surg. Oncol. J. Eur. Soc. Surg. Oncol. Br. Assoc.
Surg. Oncol. 2002; 28: 225-34.
11. Oh BK, KimYJ, Park C, ParkYN. Up-Regulation of Telomere-Bind-
ing Proteins, TRF1, TRF2, and TIN2 Is Related to Telomere Short-
ening during Human Multistep Hepatocarcinogenesis.Am. J. Pathol.
2005; 166: 73-80.
12. Zhou Q, Lui VWY, Yeo W. Targeting the PI3K/Akt/mTOR pathway
in hepatocellular carcinoma. Future Oncol. Lond. Engl. 2011; 7:
1149-67.
13. Carnero A, Paramio JM. The PTEN/PI3K/AKT Pathway in vivo,
Cancer Mouse Models. Front. Oncol. 2014; 4: 252.
14. Liu P, Cheng H, Roberts TM, Zhao JJ. Targeting the phosphoinositi-
de 3-kinase (PI3K) pathway in cancer. Nat. Rev. Drug Discov. 2009;
8, 627–644.
15. Ebi H, Corcoran RB, Singh A, Chen Z, Song Y, Lifshits E, et al. Re-
ceptor tyrosine kinases exert dominant control over PI3K signaling
in human KRAS mutant colorectal cancers. J. Clin. Invest. 2011;
121: 4311-21.
16. Byles V, Covarrubias AJ, Ben-Sahra I, Lamming DW, Sabatini DM,
Manning BD, et al. The TSC-mTOR pathway regulates macrophage
polarization. Nat. Commun. 2013; 4: 2834.
17. Marfe G, Di Stefano C, Gambacurta A, Ottone T, Martini V, Abru-
zzese E, et al. Sphingosine kinase 1 overexpression is regulated by
signaling through PI3K, AKT2, and mTOR in imatinib-resistant
chronic myeloid leukemia cells. Exp. Hematol. 2011; 39; 653-65.
18. Athar, M., and Kopelovich, L. Rapamycin and mTORC1 Inhibition
in the Mouse: Skin Cancer Prevention. Cancer Prev. Res. Phila. Pa.
2011; 4: 957-61.
19. Jiang BH, Liu LZ. PI3K/PTEN Signaling in Angiogenesis and Tum-
origenesis. Adv. Cancer Res. 2009; 102: 19-65.
20. Mukohara T. PI3K mutations in breast cancer: prognostic and ther-
apeutic implications. Breast Cancer Targets Ther. 2015; 7: 111-23.
21. Scheffler M, Bos M, Gardizi M, König K, Michels S, Fassunke J,
et al. PIK3CA mutations in non-small cell lung cancer (NSCLC):
Genetic heterogeneity, prognostic impact and incidence of prior ma-
lignancies. Oncotarget. 2014; 6: 1315-26.
22. Matsuoka T, Yashiro M. The Role of PI3K/Akt/mTOR Signaling in
Gastric Carcinoma. Cancers. 2014; 6: 1441-63.
23. Polivka J, Janku F. Molecular targets for cancer therapy in the PI3K/
AKT/mTOR pathway. Pharmacol. Ther. 2014; 142: 164-75.
24. Tahtouh R, Azzi AS, Alaaeddine N, Chamat S, Bouharoun-Tayoun
H, Wardi L, et al. Telomerase inhibition decreases alpha-fetoprotein
expression and secretion by hepatocellular carcinoma cell lines: in
vitro and in vivo study. PloS One. 2015; 10: e0119512.
25. Miura N, Osaki Y, Nagashima M, Kohno M, Yorozu K, Shomori K,
et al. A novel biomarker TERTmRNA is applicable for early detec-
tion of hepatoma. BMC Gastroenterol. 2010; 10: 46.
26. Zhu M, Guo J, Li W, Xia H, Lu Y, Dong X, et al. HBx induced AFP
receptor expressed to activate PI3K/AKT signal to promote expres-
sion of Src in liver cells and hepatoma cells. BMC Cancer. 2015; 15.
27. Lee YK, Chung HH, Kim JW, Song YS, Park NH. Expression of
phosphorylated Akt and hTERT is associated with prognosis of epi-
thelial ovarian carcinoma. Int. J. Clin. Exp. Pathol. 2015; 8: 14971-
6.
28. Xie S, Chen M, Yan B, He X, Chen X, Li D. Identification of a Role
for the PI3K/AKT/mTOR Signaling Pathway in Innate Immune
Cells. PLoS ONE. 2014; 9.
29. Hideshima T, Nakamura N, Chauhan D, Anderson KC. Biologic
sequelae of interleukin-6 induced PI3-K/Akt signaling in multiple
myeloma. Oncogene. 2001; 20: 5991-6000.
30. Salgado R, Junius S, Benoy I, Van Dam P, Vermeulen P, Van Marck
E, et al. Circulating interleukin-6 predicts survival in patients with
metastatic breast cancer. Int. J. Cancer. 2003; 103: 642-6.
31. Bataille R, Jourdan M, Zhang XG, Klein B. Serum levels of inter-
leukin 6, a potent myeloma cell growth factor, as a reflect of disease
severity in plasma cell dyscrasias. J. Clin. Invest. 1989; 84: 2008-11.
32. Zhang GJ, Adachi I. Serum interleukin-6 levels correlate to tumor
progression and prognosis in metastatic breast carcinoma. Antican-
cer Res. 1999; 19: 1427-32.
33. Bellon M, Nicot C. Central role of PI3K in transcriptional activation
of hTERT in HTLV-I-infected cells. Blood. 2008; 112: 2946-55.
34. Kaminska breast cancer risk factor. 2017.
35. Belair CD, Yeager TR, Lopez PM, Reznikoff CA. Telomerase activ-
ity: A biomarker of cell proliferation, notmalignanttransformation.
Proc. Natl. Acad. Sci. U. S. A. 1997; 94: 13677-82.
36. Levav-Cohen Y, Haupt S, HAupt Y. Mdm2 in growth signaling and
cancer. 2005; 23(3): 183-92.
37. Nagaraj NS, Datta PK. Targeting the Transforming Growth Factor-β
Signaling Pathway in Human Cancer. Expert Opin. Investig. Drugs.
2010; 19: 77-91.
38. Yamada D, Kobayashi S, Wada H, Kawamoto K, Marubashi S, Egu-
chi H, et al. Role of crosstalk between interleukin-6 and transform-
ing growth factor-beta 1 in epithelial-mesenchymal transition and
chemoresistance in biliary tract cancer. Eur. J. Cancer Oxf. Engl.
2013; 49; 1725-40.
39. Treon SP, Anderson KC. Interleukin-6 in multiple myeloma and re-
lated plasma cell dyscrasias. Curr. Opin. Hematol. 1998; 5: 42-8.
13. clinicsofoncology.com 13
Volume 6 Issue 17 -2022 Research Article
40. Smith PC, Hobisch A, Lin DL, Culig Z, Keller ET. Interleukin-6 and
prostate cancer progression. Cytokine Growth Factor Rev. 2001; 12:
33-40.
41. Potapovich A, Pastore S, Kostyuk V, Lulli D, Mariani V, De Luca C,
et al. α-Fetoprotein as a modulator of the pro-inflammatory response
of human keratinocytes. Br. J. Pharmacol. 2009; 158: 1236-47.
42. Zheng L, Gong W, Liang P, Huang X, You N, Han KQ, et al. Effects
of AFP-activated PI3K/Akt signaling pathway on cell proliferation
of liver cancer. Tumour Biol. J. Int. Soc. Oncodevelopmental Biol.
Med. 2014; 35: 4095-9.
43. Zhu Z, Mi N, Li J, Huang X, Wang L, Zheng L. Expressions and
significances of PI3K, p-AKT and AFP protein in hepatocellular car-
cinoma. J. Reg. Anat. Oper. Surg. 2011; 3: 10.
44. Barashi N, Weiss ID, Wald O, Wald H, Beider K, Abraham M, et
al. Inflammation-induced hepatocellular carcinoma is dependent on
CCR5 in mice. Hepatol. Baltim. Md. 2013; 58: 1021-30.
45. Capece D, Fischietti M, Verzella D, Gaggiano A, Cicciarelli G, Tes-
sitore A, et al. The inflammatory microenvironment in hepatocel-
lular carcinoma: a pivotal role for tumor-associated macrophages.
BioMed Res. Int. 2013; 187204.
46. Bu X, Jia F, Wang W, Guo X, Wu M, Wei L. Coupled down-regula-
tion of mTOR and telomerase activity during fluorouracil-induced
apoptosis of hepatocarcinoma cells. BMC Cancer. 2007; 7: 208.
47. Kawauchi K, Ihjima K, Yamada O. IL-2 increases human telomerase
reverse transcriptase activity transcriptionally and posttranslation-
ally through phosphatidylinositol 3’-kinase/Akt, heat shock protein
90, and mammalian target of rapamycin in transformed NK cells. J.
Immunol. Baltim. Md. 1950; 174: 5261-9.